AHMEDABAD, India, Jan. 2, 2025 /PRNewswire/ -- Veeda Group has unveiled a new logo and brand identity—Veeda Lifesciences—marking a key milestone in its journey. The new brand name reflects the ...

AHMEDABAD, India, July 8, 2025 /PRNewswire/ -- Veeda Lifesciences, a global contract research organization (CRO), has announced an investment in Mango Sciences, a Boston-based healthcare AI and data ...

The India-based CRO formerly known as Veeda Group has kicked off 2025 with a brand makeover. According to a Thursday announcement, it’s now operating under the moniker of Veeda Lifesciences, which ...

In March, Veeda Clinical Research, acquired a significant minority stake in Bengaluru-based pre-clinical research firm Bioneeds India Pvt. Ltd.(HT) CX partners backed Veeda Clinical Research on ...

Veeda Clinical Research Limited has received clearance from the Securities and Exchange Board of India (SEBI) to file its initial public offering (IPO), with private equity firm CX Partners making a ...

Anglo-Indian contract research organisation (CRO) Veeda Clinical Research has launched Veeda Oncology as a vehicle to provide oncology clinical research services to the pharmaceutical and ...

Clinical research organisation Veeda Clinical Research, which is backed by domestic private equity firm CX Partners, Tuesday said it has acquired a significant minority stake in Bengaluru-based ...

Upcoming IPOs: Five companies, including Veeda Clinical Research, Shringar House of Mangalsutra, Rite Water Solutions India, Seedworks International, and LCC Projects, have received SEBI's approval to ...

Homegrown private equity (PE) firm CX Partners plans to sell part of its stake in Veeda Clinical Research Pvt. Ltd through an initial public offering (IPO) of ₹500-700 crore, two people aware of the ...

Veeda Lifesciences, a global contract research organization (CRO), has announced an investment in Mango Sciences, a Boston-based healthcare AI and data company. Through this investment, Veeda intends ...